Hyuna Kim1, Sangmoon Lee2, Murim Choi2, Hunmin Kim3, Hee Hwang3, JiEun Choi4, Jong Hee Chae1, Ki Joong Kim1, Byung Chan Lim5. 1. Department of Pediatrics, Seoul National University Children's Hospital, Seoul, South Korea. 2. Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea. 3. Department of Pediatrics, Seoul National University Bundang Hospital, Gyeonggi-do, South Korea. 4. Department of Pediatrics, Seoul National University Boramae Medical Center, Seoul, South Korea. 5. Department of Pediatrics, Seoul National University Children's Hospital, Seoul, South Korea. Electronic address: prabbit7@snu.ac.kr.
Abstract
PURPOSE: A recurrent de novo mutation in KCNC1 (c.959G > A, p.Arg320His) has been identified recently as one of the important genetic causes of progress myoclonic epilepsy (PME). The clinical phenotype resulting from this mutation has been named as myoclonus epilepsy and ataxia due to potassium channel mutation (MEAK). This finding carries important clinical implications in that autosomal dominant inheritance and de novo occurrence need to be considered when conducting genetic tests in patients with PME. We present two familial cases of MEAK in siblings with a recurrent p.Arg320His mutation in KCNC1. METHOD: Whole exome sequencing and subsequent Sanger sequencing were performed for the cases and their parents. RESULTS: A recurrent p.Arg320His mutation in KCNC1 was identified in the two brothers who showed characteristic features of MEAK: near normal early development, onset of myoclonus around 10 years of age, infrequent generalized tonic-clonic seizures, relatively mild cognitive impairment, and generalized epileptiform discharges. Interestingly, the asymptomatic mother was suspected as being mosaic for this mutation. This finding could lead to misleading inheritance patterns and make genetic diagnosis of PME more complicated. CONCLUSIONS: Our familial MEAK cases show that consideration of parental mosaicism in addition to meticulous phenotyping is needed when conducting KCNC1 genetic testing.
PURPOSE: A recurrent de novo mutation in KCNC1 (c.959G > A, p.Arg320His) has been identified recently as one of the important genetic causes of progress myoclonic epilepsy (PME). The clinical phenotype resulting from this mutation has been named as myoclonus epilepsy and ataxia due to potassium channel mutation (MEAK). This finding carries important clinical implications in that autosomal dominant inheritance and de novo occurrence need to be considered when conducting genetic tests in patients with PME. We present two familial cases of MEAK in siblings with a recurrent p.Arg320His mutation in KCNC1. METHOD: Whole exome sequencing and subsequent Sanger sequencing were performed for the cases and their parents. RESULTS: A recurrent p.Arg320His mutation in KCNC1 was identified in the two brothers who showed characteristic features of MEAK: near normal early development, onset of myoclonus around 10 years of age, infrequent generalized tonic-clonic seizures, relatively mild cognitive impairment, and generalized epileptiform discharges. Interestingly, the asymptomatic mother was suspected as being mosaic for this mutation. This finding could lead to misleading inheritance patterns and make genetic diagnosis of PME more complicated. CONCLUSIONS: Our familial MEAK cases show that consideration of parental mosaicism in addition to meticulous phenotyping is needed when conducting KCNC1 genetic testing.
Authors: Joohyun Park; Mahmoud Koko; Ulrike B S Hedrich; Andreas Hermann; Kirsten Cremer; Edda Haberlandt; Mona Grimmel; Bader Alhaddad; Stefanie Beck-Woedl; Merle Harrer; Daniela Karall; Lisa Kingelhoefer; Andreas Tzschach; Lars C Matthies; Tim M Strom; Erich Bernd Ringelstein; Marc Sturm; Hartmut Engels; Markus Wolff; Holger Lerche; Tobias B Haack Journal: Ann Clin Transl Neurol Date: 2019-06-07 Impact factor: 4.511
Authors: Xiaoyang Li; Yongsheng Zheng; Shaoyuan Li; Umesh Nair; Chong Sun; Chongbo Zhao; Jiahong Lu; Victor Wei Zhang; Snezana Maljevic; Steven Petrou; Jie Lin Journal: Ann Transl Med Date: 2021-09
Authors: He Qiuju; Zhuang Jianlong; Wen Qi; Li Zhifa; Wang Ding; Sun Xiaofang; Xie Yingjun Journal: Front Pediatr Date: 2022-03-01 Impact factor: 3.418